Fusion Antibodies plc (AIM:FAB)
London · Delayed Price · Currency is GBP · Price in GBX 10.50
0.00 (0.00%)
Aug 14, 2026, 4:11 PM GMT
Fusion Antibodies Market Cap
Fusion Antibodies has a market cap or net worth of 13.14 million as of August 14, 2026. Its market cap has decreased by -26.59% in one year.
Market Cap
13.14M
Enterprise Value
13.28M
Revenue
1.60M
Ranking
n/a
PE Ratio
n/a
Stock Price
10.50
ChartMarket Cap Chart
Since December 18, 2017, Fusion Antibodies's market cap has decreased from 27.28M to 13.14M, a decrease of -51.83%. That is a compound annual growth rate of -8.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 13.14M | -17.41% |
| Dec 31, 2025 | 15.91M | 135.22% |
| Dec 31, 2024 | 6.76M | 167.72% |
| Dec 29, 2023 | 2.53M | -78.42% |
| Dec 30, 2022 | 11.71M | -59.09% |
| Dec 31, 2021 | 28.62M | -9.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 18, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ImmuPharma | 27.39M |
| SkinBioTherapeutics | 25.59M |
| Arecor Therapeutics | 22.47M |
| IXICO | 16.35M |
| Aptamer Group | 13.82M |
| Palatin Technologies | 12.87M |
| Genflow Biosciences | 12.12M |
| Solvonis Therapeutics | 10.21M |